Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 881 All time
- Disclosed funding
- $34.2B 795 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| A AxoftCompany profile Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders | $55M | Series A | Healthtech | United States | Investors | |
| VB Vivacta BiotechnologyCompany profile Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases | $50M | Series A+Series A | Biotech | China | Investors | |
| R Develops hands-free charging solutions for autonomous electric vehicles | $13M | Series A+Series A | Robotics | Netherlands | Investors | |
| IR Provides surveillance and security technology. | $2M | Series A | Cybersecurity | United States | Investors | |
| O OpenLightCompany profile Builds silicon photonics chips and PDK tools for AI, telecom, and quantum computing markets Builds silicon photonics chips and PDK tools for AI, telecom, and quantum computing markets | $50M | Series A1Series A | Hardware | United States | Investors | |
| CA Cybord AICompany profile Provides Visual AI for electronic component inspection and supply chain resilience Provides Visual AI for electronic component inspection and supply chain resilience | $7M | Series A+Series A | Industrial tech | Israel | Investors | |
| MO Manifest OSCompany profile Powers AI-native law firms with outcomes-based fixed pricing and predictable quality Powers AI-native law firms with outcomes-based fixed pricing and predictable quality | $60M | Series A | Enterprise software | United States | Investors | |
| LP Lighthouse PharmaceuticalsCompany profile Develops novel small-molecule therapies for neurodegenerative and inflammatory diseases Develops novel small-molecule therapies for neurodegenerative and inflammatory diseases | $12M | Series A | Biotech | United States | Investors | |
| C Provides AI platform for enterprise travel and expense management | $11.5M | Series A | AI | United States | Investors | |
| FP Four PillarsCompany profile Blockchain research, institutional advisory and validator infrastructure connecting Asian and global markets. Blockchain research, institutional advisory and validator infrastructure connecting Asian and global markets. | Undisclosed | Series A | Fintech | South Korea | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.